Stay updated on GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Locations section reorganized: Maryland and Wisconsin are now listed under a new Locations header, replacing the previous Maryland Locations and Wisconsin Locations entries. The HHS Vulnerability Disclosure link was removed.
    Difference
    0.3%
    Check dated 2025-12-23T10:17:32.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:39:52.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1, a minor metadata update that does not affect study details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:11:32.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The government funding status notice banner was removed from the page, while the study details and links remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:26:53.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Results for the study have been posted on the page, with Results First Posted dates in January and February 2025. The results section includes primary and secondary outcomes such as CD8+ T cell density in tumor tissue and the pathologic complete response rate.
    Difference
    0.4%
    Check dated 2025-11-03T01:11:29.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The page has been updated to announce a new version (v3.2.0) and to clarify government operating status and potential processing delays; the previous version tag (v3.1.0) has been removed.
    Difference
    4%
    Check dated 2025-10-05T09:26:41.000Z thumbnail image

Stay in the know with updates to GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.